Back
60 Degrees Pharmaceuticals, Inc. Stock Predictions
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Sell
42
SXTP
60 Degrees Pharmaceuticals, Inc.
Last Price:
$5.10
Seasonality Move:
-46.57%
7 Day Trial
ALL ACCESS PASS
$
7
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.60 Degrees Pharmaceuticals, Inc. Stock Forecast
-
Is 60 Degrees Pharmaceuticals, Inc. Stock Undervalued?The current 60 Degrees Pharmaceuticals, Inc. [SXTP] share price is $4.84. The Score for SXTP is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
SXTP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will 60 Degrees Pharmaceuticals, Inc. Stock Go Up Next Year?
Data Unavailable
60 Degrees Pharmaceuticals, Inc. Stock Rating
Data Unavailable
60 Degrees Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
60degreespharma.com
52-Week Data
52-Week High:
24.00
52-Week Low:
1.36
Prediction Charts
Market Cap:
6.2M
Price in USD:
4.84
Volume:
1.8M
Beta:
3.06
Technical Analysis
SMA50:
3.29
SMA100:
4.51
SMA200:
6.51
52-Wk Change:
-72.94%
Stock Predictions
-
Is 60 Degrees Pharmaceuticals, Inc. stock public?Yes, 60 Degrees Pharmaceuticals, Inc. is a publicly traded company.
-
What is the 60 Degrees Pharmaceuticals, Inc. stock quote today?The 60 Degrees Pharmaceuticals, Inc. stock price is 4.84 USD today.
-
How to buy 60 Degrees Pharmaceuticals, Inc. stock online?You can buy 60 Degrees Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-6 | 2.00 | 2.06 | 2.12 | 2.00 |
| Jan-7 | 2.08 | 1.97 | 2.08 | 1.95 |
| Jan-8 | 2.02 | 2.05 | 2.09 | 1.98 |
| Jan-9 | 2.08 | 2.11 | 2.22 | 2.05 |
| Jan-12 | 2.19 | 2.28 | 2.52 | 2.12 |
| Jan-13 | 2.25 | 2.11 | 2.32 | 2.11 |
| Jan-14 | 2.20 | 1.91 | 2.20 | 1.36 |
| Jan-15 | 1.80 | 1.86 | 2.17 | 1.72 |
| Jan-16 | 1.94 | 2.44 | 2.71 | 1.88 |
| Jan-20 | 2.22 | 2.01 | 2.38 | 1.90 |
| Jan-21 | 2.05 | 2.00 | 2.13 | 1.86 |
| Jan-22 | 5.99 | 5.04 | 8.62 | 4.40 |
| Jan-23 | 4.53 | 4.54 | 5.01 | 4.18 |
| Jan-26 | 3.34 | 4.84 | 5.19 | 3.34 |
60 Degrees Pharmaceuticals, Inc. Earnings
Data Unavailable
60 Degrees Pharmaceuticals, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.72 per share, and a decrease next year of $0.00 per share.
* 60 Degrees Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.